Latest News

Biomarker could reveal why some develop post-traumatic stress disorder (PTSD)

Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), researchers report. PTSD is triggered by a terrifying event, either witnessed or experienced. Symptoms may include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event. Not everyone who experiences trauma develops PTSD, which is why the study aimed to identify biomarkers that could better measure each person's vulnerability to the disorder.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Persistent pain estimated in 19 percent of U.S. Adults

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • Animal therapy reduces anxiety, loneliness symptoms in college students

  • Why depression and aging are linked to increased disease risk

  • Panic attacks associated with fear of bright daylight

  • Fish intake associated with boost to antidepressant response

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  • Women more likely to develop anxiety and depression after heart attack

  • Why me? Many women living in poverty blame children, love life

  •